TD Private Client Wealth LLC Sells 280 Shares of Colgate-Palmolive Company $CL

TD Private Client Wealth LLC reduced its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 10.8% in the second quarter, according to its most recent filing with the SEC. The fund owned 2,309 shares of the company’s stock after selling 280 shares during the period. TD Private Client Wealth LLC’s holdings in Colgate-Palmolive were worth $210,000 as of its most recent SEC filing.

A number of other hedge funds also recently made changes to their positions in the stock. Cornerstone Wealth Management LLC lifted its holdings in shares of Colgate-Palmolive by 1.2% during the 1st quarter. Cornerstone Wealth Management LLC now owns 9,035 shares of the company’s stock worth $847,000 after acquiring an additional 110 shares during the last quarter. Redhawk Wealth Advisors Inc. lifted its holdings in shares of Colgate-Palmolive by 2.4% during the 2nd quarter. Redhawk Wealth Advisors Inc. now owns 5,467 shares of the company’s stock worth $497,000 after acquiring an additional 129 shares during the last quarter. KFG Wealth Management LLC lifted its holdings in shares of Colgate-Palmolive by 1.5% during the 1st quarter. KFG Wealth Management LLC now owns 8,835 shares of the company’s stock worth $828,000 after acquiring an additional 131 shares during the last quarter. MONECO Advisors LLC lifted its holdings in shares of Colgate-Palmolive by 2.2% during the 1st quarter. MONECO Advisors LLC now owns 6,051 shares of the company’s stock worth $567,000 after acquiring an additional 133 shares during the last quarter. Finally, Ledyard National Bank lifted its holdings in shares of Colgate-Palmolive by 4.5% during the 1st quarter. Ledyard National Bank now owns 3,094 shares of the company’s stock worth $290,000 after acquiring an additional 134 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Price Performance

CL stock opened at $79.57 on Monday. The firm’s 50-day moving average price is $84.19 and its two-hundred day moving average price is $88.69. Colgate-Palmolive Company has a 12-month low of $78.76 and a 12-month high of $104.16. The stock has a market capitalization of $64.31 billion, a price-to-earnings ratio of 22.35, a PEG ratio of 4.14 and a beta of 0.35. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 6.79.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, August 1st. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a net margin of 14.55% and a return on equity of 377.63%. The firm had revenue of $5.11 billion for the quarter, compared to analysts’ expectations of $5.03 billion. During the same quarter in the previous year, the company earned $0.91 earnings per share. The company’s revenue for the quarter was up 1.0% compared to the same quarter last year. As a group, equities analysts predict that Colgate-Palmolive Company will post 3.75 earnings per share for the current year.

Colgate-Palmolive Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 17th will be given a $0.52 dividend. The ex-dividend date is Friday, October 17th. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.6%. Colgate-Palmolive’s payout ratio is presently 58.43%.

Analyst Ratings Changes

CL has been the subject of a number of research analyst reports. Barclays lifted their price objective on shares of Colgate-Palmolive from $86.00 to $87.00 and gave the stock an “equal weight” rating in a report on Tuesday, July 15th. Wells Fargo & Company lowered their price target on shares of Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a research note on Thursday. Morgan Stanley lowered their price target on shares of Colgate-Palmolive from $104.00 to $96.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. JPMorgan Chase & Co. lowered their price target on shares of Colgate-Palmolive from $99.00 to $95.00 and set an “overweight” rating for the company in a research note on Monday, August 4th. Finally, UBS Group lowered their price target on shares of Colgate-Palmolive from $109.00 to $106.00 and set a “buy” rating for the company in a research note on Thursday, July 17th. Seven equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average price target of $97.73.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.